News
Mike Harley Appointed Chief Franchisor Officer at Galt Phranchise System
Galt Phranchise System is proud to announce the appointment of Mike Harley as its new Chief Franchisor Officer. ATLANTA, GA, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- Galt Phranchise System LLC (“GPS”) is proud to announce Mike Harley's appointment as its new...
EY unveils Dr. Barry Patel & Dr. Wade Smith as finalists for Entrepreneur Of The Year® 2025 Southeast Award
EY US unveils Dr. Barry Patel and Dr. Wade Smith of Galt Companies as an Entrepreneur Of The Year® 2025 Southeast Award finalist ATLANTA, GA, UNITED STATES, April 28, 2025 /EINPresswire.com/ — Ernst & Young LLP (EY US) announced the finalists for the prestigious...
Galt Pharmaceuticals Expands Pain Management Portfolio with Tolectin DS®
Galt Pharmaceuticals proudly announces the introduction of Tolectin DS® (Tolmetin Sodium 400mg Capsules), to it's growing non-opioid pain product portfolio. ATLANTA, GEORGIA, USA, May 9, 2024 /EINPresswire.com/ -- Galt Pharmaceuticals, a pioneer in developing...
Sure Med Compliance Announces Partnership with Galt Phranchise System to Support Better Outcomes in Pain Patients
MOBILE, Ala., DATE /PRNewswire/ -- Sure Med Compliance, a digital healthcare company focused on curbing the opioid-related overdose epidemic announces a partnership with Galt Phranchise™ System (GPS), the first and only franchisor that enables an entrepreneur or...
Galt Aims to Disrupt Status Quo with 4-Day Workweek
Galt’s decision was based on lessons offered by the pandemic, along with research showing an increase in productivity and creativity brought about by the 4-day workweek model. Galt Pharmaceuticals Co-founder and CEO Barry Patel/Courtesy of Galt Pharmaceuticals. Galt...
Galt Pharmaceuticals Acquires Oravig® (Miconazole Buccal Tablets 50mg) from Fortovia Therapeutics
As 2024 draws to a close, we take a moment to reflect on an extraordinary year that marks a turning point in our journey. After eight years of perseverance, innovation, and an unwavering commitment to helping patients, 2024 has been our best year yet at Galt Companies.
Opioid-free Pain Med Orphengesic Forte by Galt Pharmaceuticals Approved by FDA
As 2024 draws to a close, we take a moment to reflect on an extraordinary year that marks a turning point in our journey. After eight years of perseverance, innovation, and an unwavering commitment to helping patients, 2024 has been our best year yet at Galt Companies.
Innovative Pharma Company, Galt Signs 50th Franchise
Innovative Pharma Company, Galt Signs 50th FranchiseUnique business model breaks barriers to pharma industry ownership ATLANTA -- The first and only pharmaceutical company to create a unique franchise pharma concept referred to as “phranchising,” Galt Pharmaceuticals...